Differentiated thyroid cancer (DTC) is the most common endocrinological malignancy. There
are several histological variants such as papillary and follicular thyroid carcinoma. Many …

Differentiated thyroid carcinomas (DTCs) that arise from follicular cells account> 90% of
thyroid cancer (TC)[papillary thyroid cancer (PTC) 90%, follicular thyroid cancer (FTC) 10%] …

Thyroid cancer comprises different clinical and histological entities. Whereas differentiated
(DTCs) malignancies are sensitive to radioiodine therapy, anaplastic (ATCs) and medullary …

Thyroid cancer derived from follicular cells (TCDFC) comprises well-differentiated (papillary
and follicular) carcinoma, poorly differentiated carcinoma, and anaplastic carcinoma …

Thyroid cancer is the most common endocrine malignancy; it accounts for approximately 1%
of all new case of cancer each year, and its incidence has increased significantly over the …

Thyroid cancer is the most common endocrine malignancy. With a rapidly rising incidence in
recent years, novel efficient management strategies are increasingly needed for this cancer …

Although cancer outcome results from the interplay between genetics and environment,
researchers are making a great effort for applying molecular biology in the prognostication of …

Thyroid cancers stand out among solid tumours because many of the tumour-initiating
genetic events have been identified. Mutations leading to constitutive activation of MAP …

The spectrum of thyroid cancers ranges from one of the most indolent to one of the most
aggressive solid tumors identified. Conventional therapies for thyroid cancers are based on …

Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. Surgery,
chemotherapy, radiotherapy, and radioactive iodine (RAI) therapy are the standard TC …